Haruka Toyonaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Haruka Toyonaga has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Akio Katanuma
Center for Gastroenterology Teine Keijinkai Hospital Sapporo Hokkaido Japan
29 shared publications- Tsuyoshi Hayashi
Center for Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan
28 shared publications Kuniyuki Takahashi
Center for Gastroenterology Teine Keijinkai Hospital Sapporo Hokkaido Japan
26 shared publicationsToshifumi Kin
Center for Gastroenterology Teine Keijinkai Hospital Sapporo Hokkaido Japan
19 shared publications- Tatsuya Ishii
Center for Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan
18 shared publications - Akio Katanuma
Center for Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan
16 shared publications
Latest Publications
- 9 September 2026
- Published by Elsevier in Gastrointestinal Endoscopy
Delayed cholecystocolic fistula due to migration of a spiral gallbladder stent
- 9 September 2026
- Published by Elsevier in Gastrointestinal Endoscopy
Delayed cholecystocolic fistula due to migration of a spiral gallbladder stent
- 14 July 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (7) , e70237
Efficacy and Safety of Balloon Endoscopy‐Assisted Peroral Cholangiopancreatoscopy ( POCPS ) Using a Novel 9Fr Cholangioscope in Patients With Surgically Altered Anatomy: A Dual‐Center Retrospective Study (With Video)
Peroral cholangiopancreatoscopy (POCPS) is established for diagnosis and treatment of pancreatobiliary diseases in patients with normal anatomy, but has been difficult to perform in patients with surgically altered anatomy (SAA) because conventional cholangioscope systems cannot pass through the working channel of balloon endoscopes. The novel 9Fr cholangioscope (eyeMAX 9Fr; Micro‐Tech) has a 3.2‐mm outer diameter, enabling passage through the 3.2‐mm working channel of short‐type balloon endoscopes and allowing through‐the‐channel POCPS during balloon endoscopy‐assisted ERCP (BE‐ERCP) without scope exchange. We retrospectively evaluated 38 consecutive BE‐POCPS procedures using the eyeMAX 9Fr in patients with SAA at two tertiary centers in Japan. Indications included biliary stone ( n = 31), pancreatobiliary stricture ( n = 4), pancreatic stone ( n = 1), cystic duct selection ( n = 1), and migrated stent retrieval ( n = 1). Technical success was achieved in all 38 cases (100%) across five reconstruction types using both single‐balloon and double‐balloon endoscopes. For lithotripsy ( n = 32), stone fragmentation was successful in all cases, with single‐session complete stone clearance in 53.1%. For stricture evaluation ( n = 4), visual assessment–final diagnosis concordance was 75.0% (3/4) and biopsy adequacy rate was 75% (3/4); biopsy–final diagnosis concordance was 100% among adequate specimens (3/3). Adverse events occurred in three cases (7.9%), including lithotripsy‐related bile duct mucosal injury/bleeding ( n = 2), and scope‐related small bowel perforation ( n = 1). BE‐POCPS using the eyeMAX 9Fr is a feasible and safe approach enabling direct visualization, targeted biopsy, and lithotripsy in SAA patients without scope exchange.
- 14 July 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (7) , e70237
Efficacy and Safety of Balloon Endoscopy‐Assisted Peroral Cholangiopancreatoscopy ( POCPS ) Using a Novel 9Fr Cholangioscope in Patients With Surgically Altered Anatomy: A Dual‐Center Retrospective Study (With Video)
Peroral cholangiopancreatoscopy (POCPS) is established for diagnosis and treatment of pancreatobiliary diseases in patients with normal anatomy, but has been difficult to perform in patients with surgically altered anatomy (SAA) because conventional cholangioscope systems cannot pass through the working channel of balloon endoscopes. The novel 9Fr cholangioscope (eyeMAX 9Fr; Micro‐Tech) has a 3.2‐mm outer diameter, enabling passage through the 3.2‐mm working channel of short‐type balloon endoscopes and allowing through‐the‐channel POCPS during balloon endoscopy‐assisted ERCP (BE‐ERCP) without scope exchange. We retrospectively evaluated 38 consecutive BE‐POCPS procedures using the eyeMAX 9Fr in patients with SAA at two tertiary centers in Japan. Indications included biliary stone ( n = 31), pancreatobiliary stricture ( n = 4), pancreatic stone ( n = 1), cystic duct selection ( n = 1), and migrated stent retrieval ( n = 1). Technical success was achieved in all 38 cases (100%) across five reconstruction types using both single‐balloon and double‐balloon endoscopes. For lithotripsy ( n = 32), stone fragmentation was successful in all cases, with single‐session complete stone clearance in 53.1%. For stricture evaluation ( n = 4), visual assessment–final diagnosis concordance was 75.0% (3/4) and biopsy adequacy rate was 75% (3/4); biopsy–final diagnosis concordance was 100% among adequate specimens (3/3). Adverse events occurred in three cases (7.9%), including lithotripsy‐related bile duct mucosal injury/bleeding ( n = 2), and scope‐related small bowel perforation ( n = 1). BE‐POCPS using the eyeMAX 9Fr is a feasible and safe approach enabling direct visualization, targeted biopsy, and lithotripsy in SAA patients without scope exchange.
- 10 July 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (7) , e70231
Traction‐Assisted ERCP for an Intradiverticular Papilla in a Patient With Surgically Altered Anatomy
- 10 July 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (7) , e70231
Traction‐Assisted ERCP for an Intradiverticular Papilla in a Patient With Surgically Altered Anatomy
- Open Access
- 1 June 2026
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 65 (11) , 1464-1466
Successful Removal of a Stone-covered, Proximally Migrated Pancreatic Duct Stent 14 Years After Pancreaticoduodenectomy Using Double-balloon Endoscopy
An 88-year-old man presented with epigastric pain 14 years after a pancreaticoduodenectomy. A migrated stent was found in the pancreatic duct and encased in hard pancreatic stones. Double-balloon endoscopy was used to successfully remove the stent using a biopsy forceps. The procedure was challenging because of the stone formation and narrow pancreatic duct.
- 1 June 2026
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 65 (11) , 1464-1466
Open AccessSuccessful Removal of a Stone-covered, Proximally Migrated Pancreatic Duct Stent 14 Years After Pancreaticoduodenectomy Using Double-balloon Endoscopy
An 88-year-old man presented with epigastric pain 14 years after a pancreaticoduodenectomy. A migrated stent was found in the pancreatic duct and encased in hard pancreatic stones. Double-balloon endoscopy was used to successfully remove the stent using a biopsy forceps. The procedure was challenging because of the stone formation and narrow pancreatic duct.
- 6 March 2026
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 33 (6) , 499-511
Gel Immersion vs. Water Immersion Endoscopic Ultrasound for Visualization of the Duodenal Papilla and Periampullary Lesions: A Dual‐Center Retrospective Study With Blinded Evaluation of Archived Videos
Background and Study Aims: Accurate visualization of the duodenal papilla is essential during endoscopic ultrasound (EUS). Water immersion (WI)‐EUS improves papillary visibility by expanding the duodenal lumen, but maintaining sufficient water can be difficult. Gel immersion (GI)‐EUS offers more stable visualization, though comparative data remain limited. Patients and Methods: This dual‐center retrospective study included 200 patients who underwent GI‐EUS ( n = 101) or WI‐EUS ( n = 99) for ampullary evaluation. Archived videos were randomized and independently assessed by two blinded pancreatobiliary EUS experts. Delineation quality was evaluated using predefined parameters: duodenal distension, liquid retention, and artifact reduction. Optimal delineation success was defined as complete scores for all parameters. Results: GI‐EUS achieved a significantly higher optimal delineation success rate than WI‐EUS (60.4% vs. 32.3%, p < 0.001) while requiring less liquid volume (100 mL vs. 150 mL, p < 0.001). Multivariable analysis identified GI as an independent factor associated with delineation success (adjusted OR: 2.83, 95% CI: 1.43–5.57). Inter‐observer agreement was substantial, and adverse event rates were similarly low between groups. Conclusions: Compared with WI, GI‐EUS significantly improves ampullary delineation with enhanced liquid stability and clarity, supporting clinical utility in pancreatobiliary EUS evaluations.
- 6 March 2026
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 33 (6) , 499-511
Gel Immersion vs. Water Immersion Endoscopic Ultrasound for Visualization of the Duodenal Papilla and Periampullary Lesions: A Dual‐Center Retrospective Study With Blinded Evaluation of Archived Videos
Background and Study Aims: Accurate visualization of the duodenal papilla is essential during endoscopic ultrasound (EUS). Water immersion (WI)‐EUS improves papillary visibility by expanding the duodenal lumen, but maintaining sufficient water can be difficult. Gel immersion (GI)‐EUS offers more stable visualization, though comparative data remain limited. Patients and Methods: This dual‐center retrospective study included 200 patients who underwent GI‐EUS ( n = 101) or WI‐EUS ( n = 99) for ampullary evaluation. Archived videos were randomized and independently assessed by two blinded pancreatobiliary EUS experts. Delineation quality was evaluated using predefined parameters: duodenal distension, liquid retention, and artifact reduction. Optimal delineation success was defined as complete scores for all parameters. Results: GI‐EUS achieved a significantly higher optimal delineation success rate than WI‐EUS (60.4% vs. 32.3%, p < 0.001) while requiring less liquid volume (100 mL vs. 150 mL, p < 0.001). Multivariable analysis identified GI as an independent factor associated with delineation success (adjusted OR: 2.83, 95% CI: 1.43–5.57). Inter‐observer agreement was substantial, and adverse event rates were similarly low between groups. Conclusions: Compared with WI, GI‐EUS significantly improves ampullary delineation with enhanced liquid stability and clarity, supporting clinical utility in pancreatobiliary EUS evaluations.
- Open Access
Efficacy and Safety of Remimazolam Compared to Midazolam for Sedation During Endoscopic Ultrasonography: A Single‐Center Retrospective Cohort Study
Objectives: Remimazolam is a novel ultra–short‐acting benzodiazepine that may offer advantages over conventional sedatives in endoscopic procedures. Evidence for its use in pancreatobiliary endoscopic ultrasonography (EUS) is limited. We compared the efficacy and safety of remimazolam and midazolam in outpatient pancreatobiliary EUS. Methods: This retrospective study included outpatients undergoing diagnostic pancreatobiliary EUS between July 2024 and July 2025. Patients received either remimazolam (initial 0.2 mg/kg, top‐up 0.1 mg/kg [high‐risk patients: 0.16 mg/kg, 0.08 mg/kg]) or midazolam. The target sedation depth was Modified Observer's Assessment of Alertness/Sedation ≤3, procedures were performed without supplemental oxygen, and pentazocine was co‐administered. The primary outcome was rapid recovery (meeting all criteria: modified Aldrete score ≥6 at 5 min, ≥9 at 30 min, ambulation ≥3 m at 30 min). Secondary outcomes included sedation success (all: EUS completion, without >2 top‐ups within 10 min, without rescue sedation, without agitation requiring interruption), recovery time, flumazenil use, and adverse events. Results: We analyzed 139 patients (remimazolam, n = 75; midazolam, n = 64). Rapid recovery was more frequent with remimazolam (70.7% vs. 25.0%, p < 0.001). Sedation success was higher (92.0% vs. 73.4%, p = 0.005), recovery was shorter (median 34 vs. 55 min, p < 0.001), and flumazenil use was lower (4.0% vs. 45.3%, p < 0.001). Hypoxemia (SpO 2 p = 0.707), but all episodes were mild and reversible with airway support/oxygen. Hypotension was rare and comparable. Conclusions: Remimazolam provided faster recovery and higher sedation success than midazolam in outpatient pancreatobiliary EUS. Supplemental oxygen before sedation is a reasonable option to enhance safety.
Open AccessEfficacy and Safety of Remimazolam Compared to Midazolam for Sedation During Endoscopic Ultrasonography: A Single‐Center Retrospective Cohort Study
Objectives: Remimazolam is a novel ultra–short‐acting benzodiazepine that may offer advantages over conventional sedatives in endoscopic procedures. Evidence for its use in pancreatobiliary endoscopic ultrasonography (EUS) is limited. We compared the efficacy and safety of remimazolam and midazolam in outpatient pancreatobiliary EUS. Methods: This retrospective study included outpatients undergoing diagnostic pancreatobiliary EUS between July 2024 and July 2025. Patients received either remimazolam (initial 0.2 mg/kg, top‐up 0.1 mg/kg [high‐risk patients: 0.16 mg/kg, 0.08 mg/kg]) or midazolam. The target sedation depth was Modified Observer's Assessment of Alertness/Sedation ≤3, procedures were performed without supplemental oxygen, and pentazocine was co‐administered. The primary outcome was rapid recovery (meeting all criteria: modified Aldrete score ≥6 at 5 min, ≥9 at 30 min, ambulation ≥3 m at 30 min). Secondary outcomes included sedation success (all: EUS completion, without >2 top‐ups within 10 min, without rescue sedation, without agitation requiring interruption), recovery time, flumazenil use, and adverse events. Results: We analyzed 139 patients (remimazolam, n = 75; midazolam, n = 64). Rapid recovery was more frequent with remimazolam (70.7% vs. 25.0%, p < 0.001). Sedation success was higher (92.0% vs. 73.4%, p = 0.005), recovery was shorter (median 34 vs. 55 min, p < 0.001), and flumazenil use was lower (4.0% vs. 45.3%, p < 0.001). Hypoxemia (SpO 2 p = 0.707), but all episodes were mild and reversible with airway support/oxygen. Hypotension was rare and comparable. Conclusions: Remimazolam provided faster recovery and higher sedation success than midazolam in outpatient pancreatobiliary EUS. Supplemental oxygen before sedation is a reasonable option to enhance safety.
- Open Access
Migration of Fish Bones to the Bile Duct Following Hepaticojejunostomy
Objectives: Migration of fish bones into the bile duct is rare, but can cause bile duct stone formation or acute cholangitis. Herein, we examine the characteristics of this phenomenon. Methods: This single‐center, retrospective study enrolled patients with a history of fish bone extraction from the bile duct by an endoscopic procedure at our hospital between June 2016 and November 2023. Patient characteristics, treatment details, and clinical course were assessed from the electronic medical records. Results: A total of 11 patients were enrolled, including 10 who underwent subtotal stomach‐preserving pancreaticoduodenectomy with Child's reconstruction and one who underwent extrahepatic bile duct resection with choledochojejunostomy. The median time between surgery and endoscopic treatment was 84 months (range 12–124). On computed tomography (CT), all fish bones were detected as high‐density dots or linear substances in the bile duct. Endoscopic procedures were performed using single‐balloon enteroscopy. All fish bones and coexisting biliary stones were successfully removed, with a median duration of 40.5 (range 9–54) minutes. Three cases of mild cholangitis were observed and resolved with conservative treatment. Two patients had recurrence, and all cases were successfully treated endoscopically. Conclusions: This migration may occur in patients with surgically altered biliary anatomy. Most migrated fish bones can be safely detected by CT, and treated by single‐balloon enteroscopy.
Open AccessMigration of Fish Bones to the Bile Duct Following Hepaticojejunostomy
Objectives: Migration of fish bones into the bile duct is rare, but can cause bile duct stone formation or acute cholangitis. Herein, we examine the characteristics of this phenomenon. Methods: This single‐center, retrospective study enrolled patients with a history of fish bone extraction from the bile duct by an endoscopic procedure at our hospital between June 2016 and November 2023. Patient characteristics, treatment details, and clinical course were assessed from the electronic medical records. Results: A total of 11 patients were enrolled, including 10 who underwent subtotal stomach‐preserving pancreaticoduodenectomy with Child's reconstruction and one who underwent extrahepatic bile duct resection with choledochojejunostomy. The median time between surgery and endoscopic treatment was 84 months (range 12–124). On computed tomography (CT), all fish bones were detected as high‐density dots or linear substances in the bile duct. Endoscopic procedures were performed using single‐balloon enteroscopy. All fish bones and coexisting biliary stones were successfully removed, with a median duration of 40.5 (range 9–54) minutes. Three cases of mild cholangitis were observed and resolved with conservative treatment. Two patients had recurrence, and all cases were successfully treated endoscopically. Conclusions: This migration may occur in patients with surgically altered biliary anatomy. Most migrated fish bones can be safely detected by CT, and treated by single‐balloon enteroscopy.